Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02000882
What this trial is testing

STAR Cape+BKM120 MBC With Brain Met

Who this might be right for
Brain MetastasesBreast CancerMetastatic Breast Cancer
US Oncology Research 10
Not applicableUnknownNCT05826197
What this trial is testing

Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics

Who this might be right for
Breast Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 100
Not applicableTemporarily Not AvailableNCT02011880
What this trial is testing

Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer

Who this might be right for
Breast CancerBone Metastasis
Shanghai University of Traditional Chinese Medicine
Early research (Phase 1)UnknownNCT01304797
What this trial is testing

Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Merrimack Pharmaceuticals 75
Early research (Phase 1)Active Not RecruitingNCT05143229
What this trial is testing

Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00741260
What this trial is testing

Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

Who this might be right for
Breast Cancer
Puma Biotechnology, Inc. 105
Not applicableLooking for participantsNCT05795335
What this trial is testing

CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer

Who this might be right for
Breast Cancer
RenJi Hospital 172
Testing effectiveness (Phase 2)Looking for participantsNCT07685938
What this trial is testing

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Who this might be right for
Chest Wall TumorBreast CancerLung Cancer+6 more
UNC Lineberger Comprehensive Cancer Center 60
Early research (Phase 1)Study completedNCT01921335
What this trial is testing

ARRY-380 + Trastuzuamab for Breast w/ Brain Mets

Who this might be right for
Brain Metastases From HER2 and Breast CancerAdvanced HER2-positive Breast Cancer
Dana-Farber Cancer Institute 41
Testing effectiveness (Phase 2)Study completedNCT01298713
What this trial is testing

Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

Who this might be right for
Breast NeoplasmsmTor Protein
ARCAGY/ GINECO GROUP 111
Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Testing effectiveness (Phase 2)Study completedNCT02035813
What this trial is testing

DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

Who this might be right for
HER2-negative and Hormone-receptor Positive Metastatic Breast CancerHER2-negative Circulating Tumor CellsPostmenopausal Female Patients
Prof. Wolfgang Janni 116
Early research (Phase 1)Study completedNCT03218826
What this trial is testing

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Prostate Carcinoma+23 more
National Cancer Institute (NCI) 23
Not applicableStudy completedNCT00638391
What this trial is testing

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 1,600
Not applicableEnded earlyNCT00458796
What this trial is testing

Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+2 more
University of Leeds 1,500
Early research (Phase 1)Looking for participantsNCT07046923
What this trial is testing

LY4175408 in Participants With Advanced Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaEndometrial Neoplasms+2 more
Eli Lilly and Company 240
Not applicableStudy completedNCT02662868
What this trial is testing

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

Who this might be right for
Metastatic Breast Cancer
Latin American Cooperative Oncology Group 767
Not applicableLooking for participantsNCT07085442
What this trial is testing

Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery

Who this might be right for
Breast CancerAxillary Lymph Nodes DissectionAxillary Metastases+4 more
University Hospitals of Derby and Burton NHS Foundation Trust 400
Large-scale testing (Phase 3)UnknownNCT01710605
What this trial is testing

Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

Who this might be right for
Ductal Infiltrating Metastatic Breast CancerHormone-receptors Positive Breast Cancer
Institut Curie 800
Early research (Phase 1)Active Not RecruitingNCT06253520
What this trial is testing

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Who this might be right for
Metastatic Solid CancersColorectal CancerBreast Cancer+4 more
National Cancer Institute (NCI) 210
Next Page